Literature DB >> 2182631

Glycosylation of nuclear pore protein p62. Reticulocyte lysate catalyzes O-linked N-acetylglucosamine addition in vitro.

C M Starr1, J A Hanover.   

Abstract

The addition of O-linked N-acetylglucosamine (GlcNAc) to the major nuclear pore complex glycoprotein p62 was examined. Expression of the rat p62 cDNA in transfected monkey cells was detected using a rat p62-specific antipeptide antiserum and two previously described nuclear pore-specific monoclonal antibodies which require O-linked GlcNAc for binding. Although the p62 cDNA was predicted to encode a 54-kDa polypeptide, the product expressed in monkey cells migrated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis as two species of 62 and 59-kDa. Cell-free translation of the p62 in vitro transcript yielded a 59-kDa polypeptide using wheat germ extract and a 62-kDa product using a commercially available rabbit reticulocyte lysate. Several lines of evidence indicated that the 62-kDa rabbit reticulocyte lysate translation product was modified by O-linked N-acetylglucosamine; the protein bound specifically to a wheat germ agglutinin affinity column and was converted to 59 kDa when treated with jack bean beta-acetylglucosaminidase. The 59-kDa unglycosylated wheat germ translation product was converted to the 62-kDa glycosylated form upon incubation with reticulocyte lysate demonstrating that O-linked GlcNAc can be added to p62 post-translationally.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182631

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

Review 2.  Across the nuclear pores with the help of nucleoporins.

Authors:  M Carmo-Fonseca; E C Hurt
Journal:  Chromosoma       Date:  1991-12       Impact factor: 4.316

3.  O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions.

Authors:  M D Roos; K Su; J R Baker; J E Kudlow
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  O-GlcNAc occurs cotranslationally to stabilize nascent polypeptide chains.

Authors:  Yanping Zhu; Ta-Wei Liu; Samy Cecioni; Razieh Eskandari; Wesley F Zandberg; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2015-03-16       Impact factor: 15.040

5.  Post-translational O-GlcNAcylation is essential for nuclear pore integrity and maintenance of the pore selectivity filter.

Authors:  Yanping Zhu; Ta-Wei Liu; Zarina Madden; Scott A Yuzwa; Kelsey Murray; Samy Cecioni; Natasha Zachara; David J Vocadlo
Journal:  J Mol Cell Biol       Date:  2015-06-01       Impact factor: 6.216

6.  The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny.

Authors:  R Shafi; S P Iyer; L G Ellies; N O'Donnell; K W Marek; D Chui; G W Hart; J D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

7.  Combined Antibody/Lectin Enrichment Identifies Extensive Changes in the O-GlcNAc Sub-proteome upon Oxidative Stress.

Authors:  Albert Lee; Devin Miller; Roger Henry; Venkata D P Paruchuri; Robert N O'Meally; Tatiana Boronina; Robert N Cole; Natasha E Zachara
Journal:  J Proteome Res       Date:  2016-10-14       Impact factor: 4.466

8.  Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952.

Authors:  K D Greis; W Gibson; G W Hart
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Glycosylation of the c-Myc transactivation domain.

Authors:  T Y Chou; C V Dang; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose.

Authors:  Elin Holter Anthonisen; Lise Berven; Sverre Holm; Maria Nygård; Hilde I Nebb; Line M Grønning-Wang
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.